These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6342488)

  • 1. Graft pretreatment with cyclosporin A. Long-term study including four trials in one and a half years.
    Toledo-Pereyra LH; MacKenzie GH; Gordon DA; Walters J; Toben HR
    Am Surg; 1983 May; 49(5):261-70. PubMed ID: 6342488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic liver transplantation. Various immunosuppressive regimens to improve survival.
    Toledo-Pereyra LH; Bandlien KO; MacKenzie GH; Gordon DA
    Am Surg; 1984 May; 50(5):258-63. PubMed ID: 6372562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of segmental pancreatic allografts in dogs receiving cyclosporin A.
    Du Toit DF; Reece-Smith H; McShane P; Denton T; Morris PJ
    Transplantation; 1982 Apr; 33(4):432-7. PubMed ID: 6176055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor.
    Wabbijn M; Balk AH; van Domburg RT; Vantrimpont PJ; van Riemsdijk IC; Baan CC; Weimar W; van Gelder T
    Exp Clin Transplant; 2004 Jun; 2(1):201-7. PubMed ID: 15859929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
    Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New avenues in the use of cyclosporine for transplantation. Graft and donor pretreatment.
    Cederna J; Toledo-Pereyra LH; Gof S; Rios A; MacKenzie GH; Gordon DA
    Immunol Commun; 1984; 13(6):523-38. PubMed ID: 6398274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative applications of cyclosporin A to improve kidney allograft survival.
    Toledo-Pereyra LH; Mackenzie GH; Gordon DA; Gof S; Bandlien K
    J Urol; 1984 Apr; 131(4):777-80. PubMed ID: 6368871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation.
    Pedersen EB; Hansen HE; Kornerup HJ; Madsen S; Sørensen AW
    Nephrol Dial Transplant; 1993; 8(3):250-4. PubMed ID: 8385294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved patient and graft survival using cyclosporin A in cadaver renal transplantation.
    Johnson RW
    Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S81-5. PubMed ID: 3909587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclosporine on fresh and preserved orthotopic small bowel allografts.
    Toledo-Pereyra LH; Kaufmann RJ; Bergren CT
    P R Health Sci J; 1987 Dec; 6(3):147-52. PubMed ID: 3438458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of beneficial blood transfusion effect in dogs is dependent upon immunosuppressants used.
    Niessen GJ; Obertop H; Bijnen AB; Marquet RL; Jeekel J
    Transplant Proc; 1982 Jun; 14(2):400-2. PubMed ID: 7051486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total lymphoid irradiation.
    Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS
    Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of islet cells.
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Surg Gynecol Obstet; 1984 Jan; 158(1):49-56. PubMed ID: 6419360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.